The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The primary objective is to evaluate the therapeutic effect of excessive daytime sleepiness associated with narcolepsy. Both of the subjective and objective sleepiness of the patients were assessed in the experiment by repeat measures.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
12 Years to 65 Years (Child, Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Polysomnographic findings of shortened sleep latency less than 5 minutes average of Multiple Sleep Latency Test, and two or more SOREM should be fulfilled.
Age of 12 y/o to 55 y/o.
The liver and kidney functions are within normal limits.
Meeting the strict criteria of narcolepsy described above.
Wash out any medications which might enhance wakefulness or affect nocturnal sleep two weeks prior to the experiments.
Willingness to comply with the protocol and signed the written Informed Consent.
Patients whose hypersomnia was caused by severely sleep deprived, phase delayed, or suspected long sleeper.
Patients with concomitant neurological disorder and psychiatric disorders.
Patients with sleep-related breathing disorders whose apnea/hypopnea index (AHI) was 5 pauses per hour above.
Patients with Restless Leg Syndrome & Periodic Limbs Movements whose index was more than 5 per hour.